Package 0187-0007-01

{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "a2282c58-67c0-48ac-ae4f-f05e98d6f3c0", "openfda": {"nui": ["N0000175459", "N0000175466"], "unii": ["49717AWG6K"], "rxcui": ["207406", "312818"], "spl_set_id": ["adf16e64-345f-469a-b987-3fbdd17e0ac2"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Bausch Health US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (0187-0007-01)  / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS", "package_ndc": "0187-0007-01", "marketing_end_date": "20260531", "marketing_start_date": "20190827"}], "brand_name": "Virazole", "product_id": "0187-0007_a2282c58-67c0-48ac-ae4f-f05e98d6f3c0", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "0187-0007", "generic_name": "Ribavirin", "labeler_name": "Bausch Health US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Virazole", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "6 g/1"}], "application_number": "NDA018859", "marketing_category": "NDA", "marketing_end_date": "20260531", "marketing_start_date": "19860101"}